EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zhilong Huoxue Tongyu capsule attenuates intracerebral hemorrhage induced redox imbalance by modulation of Nrf2 signaling pathway

Maryam Mazhar, Guoqiang Yang, Houping Xu, Yulin Liu, Pan Liang, Luyin Yang, Roman Spáčil, Hongping Shen, Dechou Zhang, Wei Ren, Sijin Yang

Frontiers in Pharmacology · 07.06.2023 · 14

DOI: 10.3389/fphar.2023.1197433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.06.2023. Verfasst von Maryam Mazhar und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Traditional Chinese Medicine Clinical Research Base and Drug Research Center, the Affiliated Traditional Chinese Medicine Hospital of Southw…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

One of the severely debilitating and fatal subtypes of hemorrhagic stroke is intracerebral hemorrhage (ICH), which lacks an adequate cure at present. The Zhilong Huoxue Tongyu (ZLHXTY) capsule has been utilized effectively since last decade to treat ICH, in some provinces of China but the scientific basis for its mechanism is lacking.

Purpose

To investigate the neuroprotective role of ZLHXTY capsules for ICH-induced oxidative injury through the regulation of redox imbalance with the Nrf2 signaling pathway.

Methods

Autologous blood injection model of ICH in C57BL/6J mice was employed. Three treatment groups received ZLHXTY once daily through oral gavage at doses 0.35 g/kg, 0.7 g/kg, and 1.4 g/kg, started after 2 h and continued for 72 h of ICH induction. The neurological outcome was measured using a balance beam test. Serum was tested for inflammatory markers IL-1β, IL-6, and TNF-α through ELISA, oxidative stress through hydrogen peroxide content assay, and antioxidant status by total antioxidant capacity (T-AOC) assay. Nuclear extract from brain tissue was assayed for Nrf2 transcriptional factor activity. RT-qPCR was performed for Nfe2l2, Sod1, Hmox1, Nqo1, and Mgst1; and Western blotting for determination of protein expression of Nrf2, p62, Pp62, Keap, HO1, and NQO1. Fluoro-jade C staining was also used to examine neuronal damage.

Results

ZLHXTY capsule treatment following ICH demonstrated a protective effect against oxidative brain injury. Neurological scoring showed improvement in behavioral outcomes. ELISA-based identification demonstrated a significant decline in the expression of serum inflammatory markers. Hydrogen peroxide content in serum was found to be reduced. The total antioxidant capacity was also reduced in serum, but the ZLHXTY extract showed a concentration-dependent increase in T-AOC speculating at its intrinsic antioxidant potential. Nrf2 transcriptional factor activity, mRNA and protein expression analyses revealed normalization of Nrf2 and its downstream targets, which were previously elevated as a result of oxidative stress induced by ICH. Neuronal damage was also reduced markedly after ZLHXTY treatment as revealed by Fluoro-jade C staining.

Conclusion

ZLHXTY capsules possess an intrinsic antioxidant potential that can modulate the ICH-induced redox imbalance in the brain as revealed by the normalization of Nrf2 and its downstream antioxidant targets.

Schlagwörter

Stichwörter der Autor:innen

Nrf2 signallingantioxidantsintracerebal haemorrhageredox imbalancetraditional Chinese medicine

Autor:innen und Institutionen

  • National Traditional Chinese Medicine Clinical Research Base and Drug Research Center, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.
  • Institute of Integrated Chinese and Western Medicine of Southwest Medical University, Luzhou, China.
  • Research Center for Integrated Chinese and Western Medicine, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Molecular Imaging and Therapy Research Unit, Center of Radiation Research and Medical Imaging, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Preventive Treatment Center, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.
  • Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Zitieren

APA

Mazhar, M., Yang, G., Xu, H., Liu, Y., Liang, P., Yang, L., Spáčil, R., Shen, H., Zhang, D., Ren, W., & Yang, S. (2023). Zhilong Huoxue Tongyu capsule attenuates intracerebral hemorrhage induced redox imbalance by modulation of Nrf2 signaling pathway. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1197433

Vancouver

Mazhar M, Yang G, Xu H, Liu Y, Liang P, Yang L, et al. Zhilong Huoxue Tongyu capsule attenuates intracerebral hemorrhage induced redox imbalance by modulation of Nrf2 signaling pathway. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1197433

BibTeX
@article{Mazhar2023,
  author = {Mazhar, Maryam and Yang, Guoqiang and Xu, Houping and Liu, Yulin and Liang, Pan and Yang, Luyin and Spáčil, Roman and Shen, Hongping and Zhang, Dechou and Ren, Wei and Yang, Sijin},
  title = {Zhilong Huoxue Tongyu capsule attenuates intracerebral hemorrhage induced redox imbalance by modulation of Nrf2 signaling pathway},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1197433}
}
Kostenlos starten →